The Gaithersburg-based biotech just received approval to introduce its anthrax vaccine in five European countries, a move that brings the possibility of a new and important revenue stream.
from https://www.bizjournals.com/baltimore/news/2018/04/16/emergent-biosolutions-to-enter-5-new-countries.html?ana=RSS&s=article_search
via http://baltimorecheckbook.tumblr.com/post/173001881762
No comments:
Post a Comment